MannKind (MNKD) investors saw Afrezza script sales close out November with an expected recovery from the week prior which was a holiday week. For the week ending December 1st, total Afrezza sales were just over 470 scripts. This number is at the high end of my script projection model. Afrezza sales have spent the bulk of Q4 in the 400 to 500 range vs. the 300 to 400 range that was seen in Q3. Sales are growing in line with my projections, but well below what is needed to impress the street.
Chart Source – Spencer Osborne
The quarter-over-quarter numbers in terms of scripts are showing a Q4 improvement of 19.02% increase over Q3. This is growth, but slower growth than needed. The silver lining is that with new SKUs, each script contains more cartridges and thus more dollars. This dynamic creates a bump in the revenue line. That bump is nice to see, but will not continue to outpace the script growth percentage for very long. Once the channel is filled with the new SKUs, the revenue percentage gains will more closely mirror the percentages we see in scripts. In other words, the average revenue per script will level off in the weeks ahead.
Top 10 Heal Care Stocks To Buy For 2018: Alphabet Inc.(GOOGL)
- [By Lee Jackson]
Alphabet Inc. (NASDAQ: GOOGL) had the man at the top of the search giant selling shares this past week. Lawrence Page shed two blocks of 33,332 shares. The first block was priced at $802.65 a share and the second one at $804.92. The total for the combined trades was a huge $53,583,423. The consensus price target for the stock is $966.68. The shares were changing hands on Friday’s close at $807.80.
- [By Vikram Nagarkar]
This Bloomberg reportis just one of the many recent reports which suggest that advertisers could take their ad Dollars elsewhere, or bargain hard to bring down ad prices on Facebook. With advertisers growing more wary of Facebook, it won’t come as a surprise ifAlphabet Inc’s (NSDQ:GOOGL)Google, with its massive reach and scale, emerges as a natural alternative for advertisers.However, a deeper look suggests that even Google might not have as much of a squeaky clean image as many believe it does. Quoting from the same Bloomberg post:
- [By Virendra Singh Chauhan]
Apple stock is currently trading at a PE multiple of 14.09, in line with the valuation multiples of other hardware companies like HP Inc (NYSE:HPQ) and Qualcomm (NSDQ:QCOM). However, the Apple services segment is significantly different from a ‘hardware’ business, whether in terms of operations or associated cost structure. It would, therefore, be more accurate to evaluate the segment as a services business in order to gauge its ‘value.’ Two popular companies which generate a ton of services revenue are Alphabet (NSDQ:GOOGL) and Facebook (NSDQ:FB).
- [By Arie Goren]
Recently, both suppliers of graphics processing units (GPUs) NVIDIA Corporation (NSDQ:NVDA)and Advanced Micro Devices, Inc. (NSDQ:AMD)have signed new collaborations with leading cloud companies to supply their GPUs to accelerate artificial intelligence in the enterprise. NVIDIA has announced a collaboration with tech giants Microsoft Corporation (NSDQ:MSFT)and International Business Machines (NYSE:IBM), while AMD received orders from Alphabet (NSDQ:GOOGL)to supply GPUs for Google cloud platform. Investors might wonder which one of the two companies NVIDIA or AMD is going to win the GPU race to become the primary supplier for artificial intelligence uses. While right now Nvidia dominates the GPU application in AI, in my opinion, there is enough room for both companies to grow in this marker significantly. Therefore, as I see it, to take advantage of the fast-growing deep learning and artificial intelligence market, it is better to invest in shares of both companies.
- [By The Ticker Tape]
Last week ended with a string of results from some of the biggest companies in the tech sector. Positive results continued with earnings beats from Amazon.com, Inc. (NASDAQ: AMZN), Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL), and Microsoft Corporation (NASDAQ: MSFT). AMZN and GOOG also beat revenue estimates, but MSFT came up shy of Wall Street’s top-line estimates. Tech earnings continue this week with Apple Inc. (NASDAQ: AAPL) reporting fiscal Q2 results after market close tomorrow.
Top 10 Heal Care Stocks To Buy For 2018: (LVMUY)
- [By SEEKINGALPHA.COM]
(Incidentally, the operating structure and history of growth through smart acquisitions and management is a reminiscent story behind the rise of Bernard Arnault and The Arnault Family Group, which is the majority controlling shareholder in LVMH Mo毛t Hennessy Louis Vuitton S.E. (OTCPK:LVMUY) and Christian Dior SE in the ultra-luxury goods industry.)
Top 10 Heal Care Stocks To Buy For 2018: Transcananda Pipelines Ltd.(TRP)
- [By Matthew DiLallo]
After a series of setbacks in its attempts to build new oil pipelines, Canadian pipeline giant TransCanada (NYSE:TRP) completed a transformation transaction to acquire U.S. natural gas pipeline company Columbia Pipeline Group for $13 billion, which includes the assumption of debt. The key to that deal was that it increased the combined company’s near-term project pipeline to 23 billion Canadian dollars, which supports TransCanada’s ability to increase its dividend by 8% to 10% annually through 2020. After completing that deal, TransCanada made a bid to acquire all of the outstanding units that it did not own of affiliated MLP Columbia Pipeline Partners (NYSE:CPPL) in a transaction valued at $915 million. These acquisitions solidified TransCanada’s natural gas pipeline growth ambitions, enabling it to diversify away from oil pipelines.
- [By Paul Ausick]
That includes pipeline companies like Kinder Morgan Inc. (NYSE: KMI), which already operates a pipeline transporting natural gas from Texas into Mexico, and master limited partnerships (MLPs) Energy Transfer Partners L.P. (NYSE: ETP) and TransCanada Corp. (NYSE: TRP), the company that has (so far) failed to get U.S. approval for its Keystone Pipeline expansion from Canada’s oil sands across the U.S. border.
- [By WWW.KIPLINGER.COM]
Energy stocks were driven by a hefty dose of M&A during the third quarter. And that will drive returns for TransCanada Corporation (TRP) during the next one.
- [By Ben Levisohn]
In a number of articles recently, following the US recent revival and potential approval of the previously blocked Keystone XL pipeline, a number of estimates have been provided suggesting a pending boom for the US steel industry is on the horizon (and US steel stocks have reacted in kind). In fact, this optimism, we believe, peaked today when a report from one of our competitors was published claiming that, the keystone XL pipeline could increase line pipe demand by 14.7% for 2 years. The problem here, we believe, rests with the facts that: (a) TransCanada (TRP) has already taken, and paid for, the steel to build the Keystone XL pipeline (the steel currently sits in storage facilities in both Regina, Canada and Arkansas, United States), (b) neither US Steel (X; SELL), AK Steel, Steel Dynamics, or Nucor have the ability to make the specialized steel required for the miles of pipe associated with this project, to include both the thickness and pressure requirements, according to this article from Reuters, and (c) assuming some of the pipe does need replacement, this would likely come from international steel makers who are capable of producing the specialized steel (again, as highlighted in this Reuters article).
Top 10 Heal Care Stocks To Buy For 2018: TiVo Inc.(TIVO)
- [By Lisa Levin]
TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 21 percent to $9.30. The New York Times, citing sources familiar with the issue, said Rovi Corporation (NASDAQ: ROVI) is in advanced negotiations to acquire TiVo. TiVo shareholders would reportedly receive both cash and stock; however, the price tag is yet to be determined.
- [By Lisa Levin]
TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 20 percent to $9.22. The New York Times reported that Tivo and Rovi Corporation (NASDAQ: ROVI) are in merger talks.
Top 10 Heal Care Stocks To Buy For 2018: MGM Resorts International(MGM)
- [By Jon C. Ogg]
MGM Resorts International (NYSE: MGM) is also a top pick for the first quarter, and Merrill Lynch’s price objective of $33.00 was versus a recent price of $28.50. The consensus analyst target price is a tad higher at $33.86.
- [By JJ Kinahan]
The earnings parade continues as the Fed wraps up its July meeting. Biotech giant Gilead Sciences, Inc. (NASDAQ: GILD) reports today after market close, and tomorrow morning both Verizon Communications Inc. (NYSE: VZ) and MGM Resorts International (NYSE: MGM) release their second-quarter results.
- [By Wayne Duggan]
According to Deutsche Bank analyst Carlo Santarelli, news that Las Vegas Sands Corp. (NYSE: LVS) may be selling its Sands Bethlehem resort to MGM Resorts International (NYSE: MGM) could be a win-win-win for Sands, MGM and MGM Growth Properties LLC (NYSE: MGP).
Top 10 Heal Care Stocks To Buy For 2018: Agenus Inc.(AGEN)
- [By Lisa Levin] Gainers
Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
- [By Lisa Levin]
Agenus (NASDAQ: AGEN) rose 22.99% to $3.37 after the company reported positive follow-on Phase 2 results for brain cancer vaccine.
Aeropostale (NYSE: ARO) shares jumped 18.23% to $10.18 after private equity firm Sycamore Partners bought a 7.96% stake in the company.
- [By Cory Renauer]
Shares of Agenus Inc (NASDAQ:AGEN), a biopharmaceutical company developing cancer therapies, had fallen about 14.5% as of 3:20 p.m. EST on Wednesday. Investors weren’t too thrilled about its cancer vaccine’s recent clinical trial failure.
Top 10 Heal Care Stocks To Buy For 2018: MEI Pharma, Inc.(MEIP)
- [By Chris Lange]
MEI Pharma, Inc. (NASDAQ: MEIP) saw its shares make a solid gain on Thursday after the company received a crucial upgrade from Oppenheimer. Most analysts only issue price targets that are within a range of 5% to 25% for stocks, but this upgrade absolutely blows these small calls out of the water.
Top 10 Heal Care Stocks To Buy For 2018: BiondVax Pharmaceuticals Ltd.(BVXV)
- [By Chris Lange]
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) reported that the scientific journal “Vaccine” published an article citing results from its flu vaccine. The “Vaccine” article, Back to the future: Immunization with M-001, reports that blood plasma samples from people who received M-001 in 2011 (as part of BiondVax’s BVX-005 clinical trial in the elderly) showed significantly increased protective antibodies against the new epidemic 2014/15 flu strain (A/Swiss) – a strain which did not exist when M-001 was administered to the BVX-005 participants.
Top 10 Heal Care Stocks To Buy For 2018: Sinovac Biotech Ltd.(SVA)
- [By Monica Gerson]
Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.
Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.
Top 10 Heal Care Stocks To Buy For 2018: New York & Company Inc.(NWY)
- [By Lisa Levin]
Shares of New York & Company, Inc. (NYSE: NWY) got a boost, shooting up 13 percent to $2.31 as the company posted upbeat quarterly results.
The GEO Group Inc (NYSE: GEO) shares were also up, gaining 19 percent to $23.27. Following Thursday’s Department of Justice news regarding privately-managed prisons, GEO Group dropped on Thursday, but rebounded Friday after issuing a response to the DoJ.
- [By Monica Gerson]
New York & Company, Inc. (NYSE: NWY) shares dropped 42 percent to $1.72 after the company reported downbeat Q1 results and issued a weak Q2 forecast.